Twin Tree Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-94,600
Closed -$3.31M 1730
2024
Q4
$3.31M Sell
94,600
-1,000
-1% -$37.4K 0.01% 1043
2024
Q3
$3.83M Buy
+95,600
New +$4.45M 0.01% 979
2024
Q2
Sell
-5,200
Closed -$225K 1492
2024
Q1
$225K Sell
5,200
-15,800
-75% -$753K ﹤0.01% 1143
2023
Q4
$1.06M Sell
21,000
-39,800
-65% -$1.91M ﹤0.01% 1132
2023
Q3
$2.76M Buy
60,800
+54,400
+850% +$2.24M 0.01% 809
2023
Q2
$263K Buy
+6,400
New +$246K ﹤0.01% 1098
2019
Q2
Sell
-23,600
Closed -$1.92M 1396
2019
Q1
$1.92M Sell
23,600
-111,800
-83% -$7.21M 0.01% 684
2018
Q4
$7.32M Sell
135,400
-22,500
-14% -$1.15M 0.05% 401
2018
Q3
$8.14M Sell
157,900
-31,200
-16% -$1.47M 0.06% 290
2018
Q2
$7.88M Sell
189,100
-44,000
-19% -$1.95M 0.05% 317
2018
Q1
$10.3M Buy
233,100
+7,800
+3% +$396K 0.08% 204
2017
Q4
$11.3M Buy
225,300
+78,300
+53% +$4.29M 0.08% 211
2017
Q3
$7.45M Buy
+147,000
New +$7.7M 0.06% 291
2015
Q3
Sell
-4,400
Closed -$253K 1405
2015
Q2
$253K Sell
4,400
-8,900
-67% -$566K 0.01% 1025
2015
Q1
$847K Sell
13,300
-2,100
-14% -$142K 0.02% 647
2014
Q4
$951K Buy
+15,400
New +$760K 0.03% 605

Other funds holding IONS

Twin Tree Management's IONS Position: Q1 2026 in Review

Twin Tree Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 32,476 shares — an estimated $2.57M sold.

Twin Tree Management first reported a position in IONS in Q2 2015 and held it in 18 quarters. The position peaked at $3.11M in Q4 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Twin Tree Management reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Twin Tree Management sold 32,476 Ionis Pharmaceuticals shares in Q1 2026, an estimated $2.57M.
  • Twin Tree Management first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 18 quarters.
  • Twin Tree Management's Ionis Pharmaceuticals position peaked at $3.11M in Q4 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.